Inside General Motors’ quiet $51m factory upgrade and what it means for the Silverado EV
Find out how General Motors is upgrading its Bedford casting operations to support the electric Silverado and its expanding Ultium EV strategy.
Ocugen secures FDA clearance to begin OCU400 gene therapy trial: What this means for patients with retinitis pigmentosa
Find out how Ocugen’s FDA-approved OCU400 trial is shaping the future of gene therapy for retinitis pigmentosa. Read the full story today.
Can Australia’s Mt Holland lithium refinery shift the global battery supply chain balance?
Find out how Covalent Lithium’s Mt Holland refinery just cleared a major environmental hurdle—marking a key step in Australia’s battery supply chain ambitions.
Can Alembic Pharmaceuticals challenge Latuda with its FDA-approved Lurasidone Hydrochloride Tablets?
Find out how Alembic Pharmaceuticals’ FDA approval for Lurasidone Hydrochloride Tablets positions the drugmaker in the $3.7B bipolar depression market.
From accident insurance to asset management: Aegon sharpens its business focus
Aegon completes the £60 million sale of accident insurer Stonebridge to Global Premium Holdings. Find out how this move aligns with Aegon’s capital allocation and business focus.
From biosimilars to biotech gold: How Momenta scored a $6.5bn exit with J&J
Johnson & Johnson is acquiring Momenta Pharmaceuticals for $6.5 billion to expand its autoimmune pipeline. Find out what makes nipocalimab worth the bet.
Adani bets big on Rajasthan wind power as Siemens Gamesa secures one of India’s largest turbine deals
Find out how Siemens Gamesa’s massive 473MW turbine deal with Adani Green Energy is shaping the future of wind energy in India.
What Sapiens’ $19.5m Delphi acquisition means for North American MPL carriers
Find out how Sapiens' $19.5M acquisition of Delphi Technology is set to reshape the U.S. medical professional liability software market.
No drops, no plugs: How the iTEAR100 device triggers tears in 30 seconds
Olympic Ophthalmics secures FDA clearance for iTEAR100, a handheld neurostimulator that activates tear production in seconds. Find out how it could transform dry eye treatment.
Why Equinor’s coronavirus case on the Martin Linge platform is rattling North Sea oil watchers
Equinor confirms a COVID-19 case at its Martin Linge field. Find out how offshore safety protocols are evolving amid the pandemic threat.